-
2
-
-
82255192497
-
Advances in anticoagulation: Focus on dabigatran, an oral direct thrombin inhibitor
-
J.G. Augoustides Advances in anticoagulation: Focus on dabigatran, an oral direct thrombin inhibitor J Cardiothorac Vasc Anesth 25 2011 1208 1212
-
(2011)
J Cardiothorac Vasc Anesth
, vol.25
, pp. 1208-1212
-
-
Augoustides, J.G.1
-
4
-
-
77954369172
-
New oral anticoagulation drugs in cardiovascular disease
-
I. Ahrens, G.Y. Lip, K. Peter New oral anticoagulation drugs in cardiovascular disease Thromb Haemost 104 2010 49 60
-
(2010)
Thromb Haemost
, vol.104
, pp. 49-60
-
-
Ahrens, I.1
Lip, G.Y.2
Peter, K.3
-
5
-
-
77952044405
-
Assessment of laboratory assays to measure rivaroxaban - An oral, direct factor Xa inhibitor
-
M.M. Samama, J.L. Martinoli, L. LeFiem Assessment of laboratory assays to measure rivaroxaban - An oral, direct factor Xa inhibitor Thromb Haemost 103 2010 815 825
-
(2010)
Thromb Haemost
, vol.103
, pp. 815-825
-
-
Samama, M.M.1
Martinoli, J.L.2
Lefiem, L.3
-
6
-
-
84856293397
-
Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: Results of a multicenter field trial
-
[Epub ahead of print]
-
M.M. Samama, G. Contant, T.E. Spiro Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: Results of a multicenter field trial Clin Appl Thromb/Hemost 2012 [Epub ahead of print]
-
(2012)
Clin Appl Thromb/Hemost
-
-
Samama, M.M.1
Contant, G.2
Spiro, T.E.3
-
7
-
-
84856632988
-
Evaluation of anti-factor Xa chromogenic assay for the measurement of rivaroxaban concentrations using calibrators and controls
-
M.M. Samama, G. Contant, T.E. Spiro Evaluation of anti-factor Xa chromogenic assay for the measurement of rivaroxaban concentrations using calibrators and controls Thromb Haemost 107 2012 379 387
-
(2012)
Thromb Haemost
, vol.107
, pp. 379-387
-
-
Samama, M.M.1
Contant, G.2
Spiro, T.E.3
-
8
-
-
84856784474
-
Oral anticoagulation therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines
-
W. Ageno, A.S. Gallus, A. Wittkowsky Oral anticoagulation therapy: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e44S e88S
-
(2012)
Chest
, vol.141
-
-
Ageno, W.1
Gallus, A.S.2
Wittkowsky, A.3
-
9
-
-
80053571188
-
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects
-
E.S. Ferenberg, P.W. Kamphuisen, M.K. Sijpkens Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
-
(2011)
Circulation
, vol.124
, pp. 1573-1579
-
-
Ferenberg, E.S.1
Kamphuisen, P.W.2
Sijpkens, M.K.3
-
11
-
-
84655176578
-
Evaluation of prothrombin complex concentrate and recombinant activated factor VIIa to reverse rivaroxaban in a rabbit model
-
A. Godier, A. Miciot, B. Le Bonniec Evaluation of prothrombin complex concentrate and recombinant activated factor VIIa to reverse rivaroxaban in a rabbit model Anesthesiology 116 2012 94 102
-
(2012)
Anesthesiology
, vol.116
, pp. 94-102
-
-
Godier, A.1
Miciot, A.2
Le Bonniec, B.3
-
12
-
-
84857730757
-
Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal
-
P. Toth, M. Makris Prothrombin complex concentrate-related thrombotic risk following anticoagulation reversal Thromb Haemost 107 2012 599
-
(2012)
Thromb Haemost
, vol.107
, pp. 599
-
-
Toth, P.1
Makris, M.2
-
13
-
-
84855326101
-
The year in cardiothoracic and vascular anesthesia: Selected highlights from 2011
-
P.A. Patel, H. Ramakrishna, M. Andritsos The year in cardiothoracic and vascular anesthesia: Selected highlights from 2011 J Cardiothorac Vasc Anesth 26 2012 3 10
-
(2012)
J Cardiothorac Vasc Anesth
, vol.26
, pp. 3-10
-
-
Patel, P.A.1
Ramakrishna, H.2
Andritsos, M.3
-
15
-
-
45949099359
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty
-
DOI 10.1056/NEJMoa0800374
-
B.L. Eriksson, L.C. Borris, R.J. Friedman Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty N Engl J Med 358 2008 2765 2775 (Pubitemid 351930851)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.26
, pp. 2765-2775
-
-
Eriksson, B.I.1
Borris, L.C.2
Friedman, R.J.3
Haas, S.4
Huisman, M.V.5
Kakkar, A.K.6
Bandel, T.J.7
Beckmann, H.8
Muehlhofer, E.9
Misselwitz, F.10
Geerts, W.11
-
16
-
-
45949103416
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty
-
DOI 10.1056/NEJMoa076016
-
M.R. Lassen, W. Ageno, L.C. Borris Rivaroxaban versus enoxaparin for thromboprohylaxis after total knee arthroplasty N Engl J Med 358 2008 2776 2786 (Pubitemid 351930852)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.26
, pp. 2776-2786
-
-
Lassen, M.R.1
Ageno, W.2
Borris, L.C.3
Lieberman, J.R.4
Rosencher, N.5
Bandel, T.J.6
Misselwitz, F.7
Turpie, A.G.G.8
-
17
-
-
46049106502
-
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomized controlled trial
-
A.K. Kakkar, B. Brenner, O.E. Dahl Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: A double-blind, randomized controlled trial Lancet 372 2008 31 39
-
(2008)
Lancet
, vol.372
, pp. 31-39
-
-
Kakkar, A.K.1
Brenner, B.2
Dahl, O.E.3
-
18
-
-
65549169515
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomized trial
-
A.G. Turpie, M.R. Lassen, B.L. Davidson Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): A randomized trial Lancet 373 2009 1673 1680
-
(2009)
Lancet
, vol.373
, pp. 1673-1680
-
-
Turpie, A.G.1
Lassen, M.R.2
Davidson, B.L.3
-
19
-
-
78649319886
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: A meta-analysis of randomized controlled trials
-
Y.B. Cao, J.D. Zhang, H. Shen Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: A meta-analysis of randomized controlled trials Eur J Clin Pharmacol 66 2010 1099 1108
-
(2010)
Eur J Clin Pharmacol
, vol.66
, pp. 1099-1108
-
-
Cao, Y.B.1
Zhang, J.D.2
Shen, H.3
-
20
-
-
78650242199
-
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials
-
M.V. Huisman, D.J. Quinlan, O.E. Dahl Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials Circ Cardiovasc Qual Outcomes 3 2010 6562 6660
-
(2010)
Circ Cardiovasc Qual Outcomes
, vol.3
, pp. 6562-6660
-
-
Huisman, M.V.1
Quinlan, D.J.2
Dahl, O.E.3
-
21
-
-
80052341686
-
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patietns: MAGELLAN study protocol
-
A.T. Cohen, T.E. Spiro, H.R. Büller Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patietns: MAGELLAN study protocol J Thromb Thrombolysis 31 2011 407 416
-
(2011)
J Thromb Thrombolysis
, vol.31
, pp. 407-416
-
-
Cohen, A.T.1
Spiro, T.E.2
Büller, H.R.3
-
22
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
R. Bauersachs, S.D. Berkowitz, B. Brenner Oral rivaroxaban for symptomatic venous thromboembolism N Engl J Med 363 2010 2499 2510
-
(2010)
N Engl J Med
, vol.363
, pp. 2499-2510
-
-
Bauersachs, R.1
Berkowitz, S.D.2
Brenner, B.3
-
23
-
-
78650622643
-
Therapeutic potential of oral factor Xa inhibitors
-
E.M. Hylek Therapeutic potential of oral factor Xa inhibitors N Engl J Med 363 2010 2559 2561
-
(2010)
N Engl J Med
, vol.363
, pp. 2559-2561
-
-
Hylek, E.M.1
-
25
-
-
80051800555
-
New anticoagulants for prevention of stroke in patients with atrial fibrillation
-
J.F. Viles-Gonzalez, V. Fuster, J.L. Halperin New anticoagulants for prevention of stroke in patients with atrial fibrillation J Cardiovasc Electrophysiol 22 2011 948 955
-
(2011)
J Cardiovasc Electrophysiol
, vol.22
, pp. 948-955
-
-
Viles-Gonzalez, J.F.1
Fuster, V.2
Halperin, J.L.3
-
26
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
M.R. Patel, K.W. Mahaffey, J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
-
27
-
-
80054896035
-
Evaluating rivaroxaban for nonvalvular atrial fibrillation - Regulatory considerations
-
T.R. Fleming, S.S. Emerson Evaluating rivaroxaban for nonvalvular atrial fibrillation - Regulatory considerations N Engl J Med 365 2011 1557 1559
-
(2011)
N Engl J Med
, vol.365
, pp. 1557-1559
-
-
Fleming, T.R.1
Emerson, S.S.2
-
28
-
-
84856745317
-
Antithrombotic therapy for atrial fibrillation: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
J.J. You, D.E. Singer, P.A. Howard Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
-
(2012)
Chest
, vol.141
-
-
You, J.J.1
Singer, D.E.2
Howard, P.A.3
-
29
-
-
84855723464
-
A new era in secondary prevention after acute coronary syndrome
-
M.T. Roe, E.M. Ohman A new era in secondary prevention after acute coronary syndrome N Engl J Med 366 2012 85 87
-
(2012)
N Engl J Med
, vol.366
, pp. 85-87
-
-
Roe, M.T.1
Ohman, E.M.2
-
30
-
-
84857638418
-
Promise of factor Xa inhibition in acute coronary syndromes
-
L. Lee, D. Chew Promise of factor Xa inhibition in acute coronary syndromes Curr Cardiol Rep 14 2012 40 48
-
(2012)
Curr Cardiol Rep
, vol.14
, pp. 40-48
-
-
Lee, L.1
Chew, D.2
-
31
-
-
84862907587
-
Rivaroxaban in patients with a recent acute coronary syndrome
-
J.L. Mega, E. Braunwald, S.D. Wiviott Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
-
(2012)
N Engl J Med
, vol.366
, pp. 9-19
-
-
Mega, J.L.1
Braunwald, E.2
Wiviott, S.D.3
-
32
-
-
84859937777
-
Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves
-
[Epub ahead of print]
-
J.W. Eikelboom, R.G. Hart Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves Am J Hematol 2012 [Epub ahead of print]
-
(2012)
Am J Hematol
-
-
Eikelboom, J.W.1
Hart, R.G.2
-
33
-
-
84858231144
-
Mechanical aortic valve replacement in young women planning on pregnancy: Maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol
-
L.S. De Santo, G. Romano, Corte A. Della Mechanical aortic valve replacement in young women planning on pregnancy: Maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol J Am Coll Cardiol 59 2012 1110 1115
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 1110-1115
-
-
De Santo, L.S.1
Romano, G.2
Della, C.A.3
-
34
-
-
80052700689
-
A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves
-
C.R. Saeed, J.B. Frank, M. Pravin A prospective trial showing the safety of adjusted-dose enoxaparin for thromboprophylaxis of pregnant women with mechanical prosthetic heart valves Clin Appl Thromb Hemost 17 2011 313 319
-
(2011)
Clin Appl Thromb Hemost
, vol.17
, pp. 313-319
-
-
Saeed, C.R.1
Frank, J.B.2
Pravin, M.3
-
35
-
-
84858033931
-
Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement
-
e9-e9
-
A.J. Perissinotti, B. Dotson, F.A. Baciewicz Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement Ann Pharmacother 46 2012 e9-e9
-
(2012)
Ann Pharmacother
, vol.46
-
-
Perissinotti, A.J.1
Dotson, B.2
Baciewicz, F.A.3
-
36
-
-
82955205748
-
Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: Results of an in vitro study
-
A. Kaeberich, I. Reindl, U. Raaz Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: Results of an in vitro study J Thromb Thrombolysis 32 2011 417 425
-
(2011)
J Thromb Thrombolysis
, vol.32
, pp. 417-425
-
-
Kaeberich, A.1
Reindl, I.2
Raaz, U.3
-
37
-
-
68249158084
-
Apixaban or enoxaparin for thromboprophylaxis after knee replacement
-
M.R. Lassen, G.E. Raskob, A. Gallus Apixaban or enoxaparin for thromboprophylaxis after knee replacement N Engl J Med 361 2009 594 604
-
(2009)
N Engl J Med
, vol.361
, pp. 594-604
-
-
Lassen, M.R.1
Raskob, G.E.2
Gallus, A.3
-
38
-
-
77649113258
-
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): A randomized double-blind trial
-
M.R. Lassen, G.E. Raskob, A. Gallus Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): A randomized double-blind trial Lancet 375 2010 807 815
-
(2010)
Lancet
, vol.375
, pp. 807-815
-
-
Lassen, M.R.1
Raskob, G.E.2
Gallus, A.3
-
39
-
-
78650587760
-
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement
-
M.R. Lassen, A. Gallus, G.E. Raskob Apixaban versus enoxaparin for thromboprophylaxis after hip replacement N Engl J Med 363 2010 2487 2498
-
(2010)
N Engl J Med
, vol.363
, pp. 2487-2498
-
-
Lassen, M.R.1
Gallus, A.2
Raskob, G.E.3
-
40
-
-
84863477329
-
The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: Systematic review and network meta-analysis
-
[Epub ahead of print]
-
A. Cohen, P. Drost, N. Marchant The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: Systematic review and network meta-analysis Clin Appl Thromb/Hemost 2012 [Epub ahead of print]
-
(2012)
Clin Appl Thromb/Hemost
-
-
Cohen, A.1
Drost, P.2
Marchant, N.3
-
41
-
-
84858709224
-
Apixaban: An oral direct factor Xa inhibitor
-
D. Jimenez, R.D. Yusen, E. Ramacciotti Apixaban: An oral direct factor Xa inhibitor Adv Ther 29 2012 187 201
-
(2012)
Adv Ther
, vol.29
, pp. 187-201
-
-
Jimenez, D.1
Yusen, R.D.2
Ramacciotti, E.3
-
42
-
-
83155193223
-
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients
-
S.Z. Goldhaber, A. Leizorovicz, A.K. Kakkar Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
-
(2011)
N Engl J Med
, vol.365
, pp. 2167-2177
-
-
Goldhaber, S.Z.1
Leizorovicz, A.2
Kakkar, A.K.3
-
43
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
C.B. Granger, J.H. Alexander, J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
-
44
-
-
80052836882
-
A new era for anticoagulation in atrial fibrillation
-
J.L. Mega A new era for anticoagulation in atrial fibrillation N Engl J Med 365 2011 1052 1054
-
(2011)
N Engl J Med
, vol.365
, pp. 1052-1054
-
-
Mega, J.L.1
-
45
-
-
80052162121
-
Apixaban with antiplatelet therapy after acute coronary syndrome
-
J.H. Alexander, R.D. Lopes, S. James Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
-
(2011)
N Engl J Med
, vol.365
, pp. 699-708
-
-
Alexander, J.H.1
Lopes, R.D.2
James, S.3
-
46
-
-
80052635170
-
New anticoagulants: How to deal with treatment failure and bleeding complications
-
R.S. Kazmi, B.A. Lwaleed New anticoagulants: How to deal with treatment failure and bleeding complications Br J Clin Pharmacol 72 2011 593 603
-
(2011)
Br J Clin Pharmacol
, vol.72
, pp. 593-603
-
-
Kazmi, R.S.1
Lwaleed, B.A.2
-
47
-
-
77249146517
-
Laboratory monitoring of new anticoagulants
-
D.D. Castellone, E.M. Van Cott Laboratory monitoring of new anticoagulants Am J Hematol 85 2010 185 187
-
(2010)
Am J Hematol
, vol.85
, pp. 185-187
-
-
Castellone, D.D.1
Van Cott, E.M.2
-
48
-
-
84859971855
-
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors
-
[Epub ahead of print]
-
S. Kaatz, P.A. Kouides, D.A. Garcia Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors Am J Hematol 2012 [Epub ahead of print]
-
(2012)
Am J Hematol
-
-
Kaatz, S.1
Kouides, P.A.2
Garcia, D.A.3
-
49
-
-
77950457738
-
Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors
-
G. Lu, P. Luan, S. Hollenbach Reconstructed recombinant factor Xa as an antidote to reverse anticoagulation by factor Xa inhibitors J Thromb Haemost 7 suppl 20 2009 107
-
(2009)
J Thromb Haemost
, vol.7
, Issue.SUPPL. 20
, pp. 107
-
-
Lu, G.1
Luan, P.2
Hollenbach, S.3
-
50
-
-
74549191939
-
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition)
-
T.T. Horlocker, D.J. Wedel, J.C. Rowlingson Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition) Reg Anesth Pain Med 35 2010 64 101
-
(2010)
Reg Anesth Pain Med
, vol.35
, pp. 64-101
-
-
Horlocker, T.T.1
Wedel, D.J.2
Rowlingson, J.C.3
-
51
-
-
78349242482
-
Regional anesthesia and antithrombotic agents: Recommendation of the European Society of Anesthesiology
-
W. Gogarten, E. van der Meulen, H. Van Aken Regional anesthesia and antithrombotic agents: Recommendation of the European Society of Anesthesiology Eur J Anaesthesiol 27 2010 999 1015
-
(2010)
Eur J Anaesthesiol
, vol.27
, pp. 999-1015
-
-
Gogarten, W.1
Van Der Meulen, E.2
Van Aken, H.3
-
52
-
-
84860526602
-
Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
-
[Epub ahead of print]
-
D.E. Salazar, J. Mendell, H. Kastrissios Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation Thromb Haemost 2012 [Epub ahead of print]
-
(2012)
Thromb Haemost
-
-
Salazar, D.E.1
Mendell, J.2
Kastrissios, H.3
|